CATALYST PHARMACEUTICALS, INC.: cash_and_equivalents
| Value | {"amount": 130237109, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2020-12-31) |
| Status | superseded |
| Entity | CATALYST PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:07:54.785800+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/32dad2ca-6050-48e4-b7d8-15198d1b66f0
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-21-081545Retrieved: 2026-08-19T13:07:54.785800+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001369568/cash-and-equivalents/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/32dad2ca-6050-48e4-b7d8-15198d1b66f0
History
- no predecessors — first report